{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:17:47Z","timestamp":1788495467780,"version":"build-2803163510"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lung or heart\u2013lung transplantation (LT\/HLT) for severe pulmonary hypertension (PH) as the primary disease indication carries a high risk of waiting list mortality and post-transplant complications. France and the UK both have coordinated PH patient services but with different referral pathways for accessing LT services.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a comparative analysis of adult PH patients listed for LT\/HLT in the UK and France.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 211 PH patients in France (2006\u20132018) and 170 in the UK (2010\u20132019). Cumulative incidence of transplant, delisting and waiting list death within 3\u2005years were 81%, 4% and 11% in France<jats:italic>versus<\/jats:italic>58%, 10% and 15% in the UK (p&lt;0.001 for transplant and delisting; p=0.1 for death). Median non-priority waiting time was 45\u2005days in France<jats:italic>versus<\/jats:italic>165\u2005days in the UK (p&lt;0.001). High-priority listing occurred in 54% and 51% of transplanted patients respectively in France and the UK (p=0.8). Factors associated with achieving transplantation related to recipients\u2019 height, male sex, clinical severity and priority listing status. 1-year post-transplant survival was 78% in France and 72% in the UK (p= 0.04).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Access to transplantation for PH patients is better in France than in the UK where more patients were delisted due to clinical deterioration because of longer waiting time. High rates of priority listing occurred in both countries. Survival for those achieving transplantation was slightly better in France. Ensuring optimal outcomes after transplant listing for PH patients is challenging and may involve early listing of higher risk patients, increasing donor lung utilisation and improving allocation rules for these specific patients.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00521-2023","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:05:58Z","timestamp":1704992758000},"page":"00521-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of listing for lung and heart\u2013lung transplantation in pulmonary hypertension: comparative experience in France and the UK"],"prefix":"10.1183","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-4666","authenticated-orcid":false,"given":"Pauline","family":"Prad\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Le Pavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Meachery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-8975","authenticated-orcid":false,"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2024101712120489000_10.1.00521-2023.1","unstructured":"NHS Blood and Transplant . Organ and Tissue Donation and Transplantation Activity Report 2020\/21. Date last accessed: 15 October 2023. https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/24053\/activity-report-2020-2021.pdf"},{"key":"2024101712120489000_10.1.00521-2023.2","unstructured":"Agence de la Biomedecine . Organ retrieval for transplantation: General report. Date last accessed: 26 May 2023. https:\/\/rams.agence-biomedecine.fr\/le-prelevement-dorganes-en-vue-de-greffe-0"},{"key":"2024101712120489000_10.1.00521-2023.3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chest.2023.04.047","article-title":"Lung transplantation for pulmonary arterial hypertension","volume":"164","author":"Kolaitis","year":"2023","journal-title":"Chest"},{"key":"2024101712120489000_10.1.00521-2023.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01906-2018"},{"key":"2024101712120489000_10.1.00521-2023.5","doi-asserted-by":"crossref","first-page":"e12137","DOI":"10.1002\/pul2.12137","article-title":"The evolution of survival of pulmonary arterial hypertension over 15\u2005years","volume":"12","author":"Hendriks","year":"2022","journal-title":"Pulm Circ"},{"key":"2024101712120489000_10.1.00521-2023.6","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2024101712120489000_10.1.00521-2023.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.08.001"},{"key":"2024101712120489000_10.1.00521-2023.8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000001523","article-title":"Predicting primary graft dysfunction after lung transplantation: trying to catch it early","volume":"101","author":"Diamond","year":"2017","journal-title":"Transplantation"},{"key":"2024101712120489000_10.1.00521-2023.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00889-2017"},{"key":"2024101712120489000_10.1.00521-2023.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01889-2018"},{"key":"2024101712120489000_10.1.00521-2023.11","unstructured":"Jakubowski E, Busse R. Directorate General for Research, European Parliament. Health care systems in the EU: a comparative study. Date last accessed: 11 April 2023. www.europarl.europa.eu\/workingpapers\/saco\/pdf\/101_en.pdf"},{"key":"2024101712120489000_10.1.00521-2023.12","first-page":"179","article-title":"Lung transplantation in Germany since the introduction of the lung allocation score","volume":"114","author":"Gottlieb","year":"2017","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"2024101712120489000_10.1.00521-2023.13","unstructured":"Spanish National Transplant Organisation . Newsletter Transplant 2022 \u2013 European Directorate for the Quality of Medicines & HealthCare (EDQM). Date last updated: 27 September 2022. Date last accessed: 11 April 2023. www.edqm.eu\/en\/-\/newsletter-transplant-2022-shows-a-global-increase-in-donation-and-transplantation-figures-lessons-learnt-from-covid-19-pandemic"},{"key":"2024101712120489000_10.1.00521-2023.14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.athoracsur.2017.02.034","article-title":"Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension","volume":"104","author":"Savale","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2024101712120489000_10.1.00521-2023.15","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211731"},{"key":"2024101712120489000_10.1.00521-2023.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"2024101712120489000_10.1.00521-2023.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024101712120489000_10.1.00521-2023.18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest"},{"key":"2024101712120489000_10.1.00521-2023.19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13717"},{"key":"2024101712120489000_10.1.00521-2023.20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr213"},{"key":"2024101712120489000_10.1.00521-2023.21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.healun.2022.06.001","article-title":"Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation","volume":"41","author":"Vicaire","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2024101712120489000_10.1.00521-2023.22","unstructured":"Agence de la Biom\u00e9decine . Agence de la biom\u00e9decine \u2013 French National Agency for Transplantation \u2013 Cardiopulmonary and Lung Transplant Statistics. Date last accessed: 8 November 2023. https:\/\/rams.agence-biomedecine.fr\/greffe-cardio-pulmonaire-et-pulmonaire-0"},{"key":"2024101712120489000_10.1.00521-2023.23","unstructured":"NHS Blood and Transplant . ODT \u2013 Organ Donation and Transplantation. ODT Clinical \u2013 NHS Blood and Transplant. Date last accessed: 8 November 2023. www.odt.nhs.uk\/"},{"key":"2024101712120489000_10.1.00521-2023.24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2024101712120489000_10.1.00521-2023.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201909-1771OC"},{"key":"2024101712120489000_10.1.00521-2023.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01232-2022"},{"key":"2024101712120489000_10.1.00521-2023.27","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/CIRCULATIONAHA.122.061501","article-title":"Serum and pulmonary expression profiles of the activin signaling system in pulmonary arterial hypertension","volume":"147","author":"Guignabert","year":"2023","journal-title":"Circulation"},{"key":"2024101712120489000_10.1.00521-2023.28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ehjdh\/ztac022","article-title":"Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension","volume":"3","author":"Alabed","year":"2022","journal-title":"Eur Heart J Digit Health"},{"key":"2024101712120489000_10.1.00521-2023.29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.athoracsur.2020.02.061","article-title":"Increased cPRA is associated with increased waitlist time and mortality in LTx","volume":"110","author":"Barac","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2024101712120489000_10.1.00521-2023.30","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00020-2017"},{"key":"2024101712120489000_10.1.00521-2023.31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.202201-0217OC","article-title":"The lung allocation score remains inequitable for patients with PAH, even after the 2015 revision","volume":"207","author":"Kolaitis","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712120489000_10.1.00521-2023.32","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1016\/j.healun.2020.01.475","article-title":"Exceptional LAS requests in Eurotransplant: analysis of an 8-year effort to improve lung allocation for precarious patients","volume":"39","author":"Vos","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2024101712120489000_10.1.00521-2023.33","unstructured":"Spanish National Transplant Organisation . Archive of Newsletter Transplant from European Directorate for the Quality of Medicines & HealthCare (EDQM). Date last accessed: 11 April 2023. https:\/\/freepub.edqm.eu\/publications"},{"key":"2024101712120489000_10.1.00521-2023.34","unstructured":"Department of Health and Social Care, UK Government . Opt-out organ donation: Max and Keira's Bill passed into law. GOV.UK. Date last updated: 15 March 2019. Date last accessed: 26 April 2023. www.gov.uk\/government\/news\/opt-out-organ-donation-max-and-keira-s-bill-passed-into-law"},{"key":"2024101712120489000_10.1.00521-2023.35","unstructured":"Rushton S , Hogg R . Centre specific cardiothoracic organ utilisation rates, NHS Blood and Transplant Cardiothoracic Advisory Group (CTAG). March 2019. https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/16005\/centre-specific-cardiothoracic-organ-utilisation-rates.pdf"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00521-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:32:28Z","timestamp":1740375148000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00521-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1183\/23120541.00521-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00521-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}